A carregar...
A phase I study of nelfinavir concurrent with temozolomide and radiotherapy in patients with glioblastoma multiforme
We conducted a phase I trial to examine the maximally tolerated dose (MTD) of the oral protease inhibitor nelfinavir (NFV) in combination with temozolomide and concurrent radiotherapy in patients with glioblastoma and to gather preliminary data for response. The study was conducted in patients with...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4116080/ https://ncbi.nlm.nih.gov/pubmed/24194293 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11060-013-1303-3 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|